OncoCyte Corporation (OCX) Financials

Stock symbol OCX is outdated, potentially delisted? Maybe it is available on other exchange?

OCX Assets vs Liabilities

Date	Assets	Liabilities
March 31, 2025	60.4 million	50.1 million
Dec. 31, 2024	35.1 million	47.4 million
Sept. 30, 2024	70.2 million	60.5 million
June 30, 2024	74.7 million	52.0 million

OCX Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
March 31, 2025	-5.9 million	473000
Dec. 31, 2024	-5.6 million	549000
Sept. 30, 2024	-5.3 million	354000
June 30, 2024	-6.2 million	202000

OCX Net Income

No data available :(

OCX Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
March 31, 2025	31.0 million	2.1 million	3.5 million
Dec. 31, 2024	8.6 million	2.4 million	2.4 million
Sept. 30, 2024	3.4 million	2.7 million	4.0 million
June 30, 2024	9.3 million	2.6 million	3.7 million

OCX Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
March 31, 2025	25.7 million
Dec. 31, 2024	13.1 million
Sept. 30, 2024	13.7 million
June 30, 2024	12.9 million

OCX Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
March 31, 2025	307000	2.9 million	4.3 million	1.2 million
Dec. 31, 2024	214000	1.9 million	3.4 million	1.2 million
Sept. 30, 2024	215000	2.8 million	3.6 million	1.0 million
June 30, 2024	191000	2.5 million	3.3 million	853000

OCX Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
March 31, 2025	2.1 million	813000
Dec. 31, 2024	1.5 million	511000
Sept. 30, 2024	115000	65000
June 30, 2024	104000	54000

OCX

Price: $3.20

52 week price:

1.92

4.75

Earnings Per Share: -3.79 USD

P/E Ratio: -0.81

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 412400

Market Capitalization: 87.8 million

Links:

OCX on Yahoo Finance